Managing perianal Crohn’s fistula in the anti-TNFα era

被引:0
|
作者
P. Tozer
D. W. Borowski
A. Gupta
N. Yassin
R. Phillips
A. Hart
机构
[1] Imperial College London,Fistula Research Unit, St Mark’s Hospital
[2] University Hospital North Tees,undefined
来源
Techniques in Coloproctology | 2015年 / 19卷
关键词
Perianal fistula; Crohn’s disease; Surgery; Biological therapies; Anti-tumour necrosis factor-α;
D O I
暂无
中图分类号
学科分类号
摘要
Perianal fistulas in Crohn’s disease are common and difficult to treat. Their aetiology is poorly understood. Assessment is clinical, endoscopic and radiological, and management is undertaken by a multidisciplinary team of gastroenterologists, surgeons and radiologists. Surgical drainage of the fistula tract system with the placement of loose setons precedes combined therapy with immunosuppressant and anti-TNFα agents in most patients. Proctitis should be rigorously eliminated where possible. Definitive surgical repair is sometimes possible and diversion or proctectomy are occasionally required. Combined medical and surgical management represents a promising avenue for the future.
引用
收藏
页码:673 / 678
页数:5
相关论文
共 50 条
  • [1] Managing perianal Crohn's fistula in the anti-TNFα era
    Tozer, P.
    Borowski, D. W.
    Gupta, A.
    Yassin, N.
    Phillips, R.
    Hart, A.
    TECHNIQUES IN COLOPROCTOLOGY, 2015, 19 (11) : 673 - 678
  • [2] Fistula Healing in Perianal Crohn's Disease - With or Without Anti-TNF Therapy?
    Yassin, N. A.
    Askari, A.
    Ferrari, L.
    Faiz, O.
    Warusavitarne, J.
    Phillips, R.
    Hart, A.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S273 - S274
  • [3] Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients
    Strik, Anne S.
    Lowenberg, Mark
    Buskens, Christianne J.
    Gecse, Krisztina B.
    Ponsioen, Cyriel, I
    Bemelman, Willem A.
    D'Haens, Geert R.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (04) : 453 - 458
  • [4] Lack of anti-TNF drugs levels in fistula tissue: A reason for non-response in Crohn's perianal fistula?
    Adegbola, S.
    Sarafian, M.
    Sahnan, K.
    Pechlivanis, A.
    Phillips, R.
    Knowles, C.
    Haddow, J.
    Warusavitarne, J.
    Faiz, O.
    Tozer, P.
    Holmes, E.
    Hart, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S330 - S331
  • [5] Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients
    Strik, A.
    Lowenberg, M.
    Ponsioen, C.
    Gecse, K.
    Buskens, C.
    Bemelman, W.
    D'Haens, G.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S4 - S4
  • [6] Local injection of anti-TNF for perianal fistulising Crohn's disease
    Ommer, A.
    COLOPROCTOLOGY, 2018, 40 (01) : 51 - 52
  • [7] Lack of anti-TNF drugs levels in fistula tissue - a reason for nonresponse in Crohn's perianal fistulating disease?
    Adegbola, Samuel O.
    Sarafian, Magali
    Sahnan, Kapil
    Pechlivanis, Alexandros
    Phillips, Robin K. S.
    Warusavitarne, Janindra
    Faiz, Omar
    Haddow, James
    Knowles, Charles
    Tozer, Phil
    Holmes, Elaine
    Hart, Ailsa
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (01) : 18 - 26
  • [8] Review of local injection of anti-TNF for perianal fistulising Crohn's disease
    Adegbola, Samuel O.
    Sahnan, Kapil
    Tozer, Philip J.
    Phillips, Robin K. S.
    Faiz, Omar D.
    Warusavitarne, Janindra
    Hart, Ailsa
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2017, 32 (11) : 1539 - 1544
  • [9] Review of local injection of anti-TNF for perianal fistulising Crohn’s disease
    Samuel O. Adegbola
    Kapil Sahnan
    Philip J Tozer
    Robin KS Phillips
    Omar D Faiz
    Janindra Warusavitarne
    Ailsa Hart
    International Journal of Colorectal Disease, 2017, 32 : 1539 - 1544
  • [10] Anti-TNF and Fistulising Perianal Crohn's Disease: Use in Clinical Practice
    Bourikas, Leonidas A.
    Koutroubakis, Ioannis E.
    CURRENT DRUG TARGETS, 2010, 11 (02) : 187 - 197